Free Trial

ConvaTec Group (CNVVY) Stock Forecast & Price Target

ConvaTec Group logo
$11.94 +0.28 (+2.40%)
(As of 11/22/2024 ET)

ConvaTec Group - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
0
Buy
3

Based on 3 Wall Street analysts who have issued ratings for ConvaTec Group in the last 12 months, the stock has a consensus rating of "Strong Buy." Out of the 3 analysts, 3 have given a strong buy rating for CNVVY.

Consensus Price Target

N/A

Get the Latest News and Ratings for CNVVY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for ConvaTec Group and its competitors.

Sign Up

CNVVY Analyst Ratings Over Time

TypeCurrent Forecast
11/24/23 to 11/23/24
1 Month Ago
10/25/23 to 10/24/24
3 Months Ago
8/26/23 to 8/25/24
1 Year Ago
11/24/22 to 11/24/23
Strong Buy
3 Strong Buy rating(s)
3 Strong Buy rating(s)
3 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
2 Buy rating(s)
5 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Consensus Rating
Strong Buy
Strong Buy
Strong Buy
Moderate Buy

CNVVY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CNVVY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

ConvaTec Group Stock vs. The Competition

TypeConvaTec GroupMedical CompaniesS&P 500
Consensus Rating Score
4.00
2.80
2.50
Consensus RatingStrong BuyModerate BuyModerate Buy
Predicted UpsideN/A27,073.49% Upside7.66% Upside
News Sentiment Rating
Neutral News

See Recent CNVVY News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/6/2024Berenberg Bank
2 of 5 stars
S. England
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
7/31/2024Barclays
3 of 5 stars
H. Al-Wakeel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
6/26/2024UBS Group
4 of 5 stars
G. Doyle
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
9/7/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeSector Perform ➝ Outperform
9/5/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy
8/9/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetGBX 250 ➝ GBX 260
8/7/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
8/3/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetGBX 290 ➝ GBX 320
7/7/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeReduce ➝ Hold
5/23/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetGBX 220 ➝ GBX 225
3/7/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 12:13 AM ET.


CNVVY Forecast - Frequently Asked Questions

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ConvaTec Group in the last twelve months. There are currently 3 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "strong buy" CNVVY shares.

According to analysts, ConvaTec Group's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Analysts like ConvaTec Group more than other "medical" companies. The consensus rating for ConvaTec Group is Strong Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CNVVY compares to other companies.


This page (OTCMKTS:CNVVY) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners